Recite me link

1. Since 1 November 2018, how many requests for prescriptions of unlicensed cannabis-based medical products (CBMPs) have been made though your Trust’s Drugs and Therapeutics Committee (or similar approval process)?
2. How many of these requests were approved?
3. How many requests were rejected?
4. Where a request was rejected, please provide the reason for the decision.

Download response Prescriptions of unlicensed cannabis-based medical products (CBMPs). 131020